TPTX

TPTX Stock Soars 115% as Bristol-Myers Announces Takeover of Turning Point Therapeutics

Turning Point Therapeutics (TPTX) stock is rocketing higher on Friday following news of a deal with Bristol-Myers Squibb (BMY).

The Top Performing Sector in 2020 Will Be …

The future of healthcare will really start to take shape this year, and the next decade will bring advancements that we can only imagine in our wildest dreams.